Eyeworld

71 May 2018 EW MEETING REPORTER Dakota, and Iqbal "Ike" Ahmed, MD, Toronto, Canada—pushed a button to turn their chair and see the contestant if they agreed with their position and wanted to men- tor/team up. If more than one judge turned, they were given the oppor- tunity to share why they should be chosen as mentor. From there, the contestant-judge duo faced a panel, which included Vance Thompson, MD, Sioux Falls, South Dakota, Richard Lindstrom, MD, Minne- apolis, Mitchell Jackson, MD, Lake Villa, Illinois, and Rosa Braga-Mele, MD, Toronto, Canada, who provid- ed counter arguments. After all contestants had com- peted, the audience voted for the contestant-judge team who they thought had the best presentation. Ultimately, contestant Blake Wil- liamson, MD, Baton Rouge, Louisi- ana, and Dr. Yeu were the winners. Dr. Williamson presented on "Pres- byopia in the Farsighted Future." Dr. Williamson said he thought that ophthalmologists would be treating presbyopia with surgical or topical options within the next decade. Dr. Williamson said near vision has become more valuable over time with dependence on the computer and now the ubiquitous smart- phone. Yet there hasn't been much change in modes of presbyopia correction; the most common way is reading glasses and bifocals. But there's good news; we're in a renaissance for presbyopia, Dr. Williamson said. There were five options for surgical presbyopia cor- rection 5 years ago; now there are up to 30 options that could be available in the near future. Dr. Williamson gave a brief overview of the few he thinks will be most transformative. These included allogenic inlays and onlays (Allotex, Zurich, Switzerland), the Light Adjustable Lens (RxSight, Aliso Viejo, California), and refrac- tive indexing (Perfect Lens, Irvine, California). Dr. Williamson said he sees a future in the "topical presby-lution," mentioning several topical drops that are in clinical testing that use different modes of action. analyzes four different types of inno- vation and the kinds of individuals who represent them. The first type of innovation is creativity, or innovation to do new things, represented by the artist, Mr. DeGraff said. These individuals are creative risk-takers. The second type is control, or innovation to do things right, represented by the engineer. These individuals are more predictable but not usually risk-takers. The third type is collaboration, or innovation to do things that last, represented by the sage. These in- dividuals are cooperative and focus on community. The fourth and final type is competition, or innovation to do things now, represented by the athlete. These individuals are fast yet can be contentious and demanding. The key to moving forward is harnessing the tension between these individuals and the types of innovation they represent, accord- ing to Mr. DeGraff. He recommend- ed pairing the high risk-taking artist together with the low risk-taking engineer and the short-term per- forming athlete with the long-term performing sage. Bringing these types of people together will create hybrid ideas and better ways of do- ing things, he said. Editors' note: Mr. DeGraff has no financial interests related to his comments. The Voice of Ophthalmology premieres at ASCRS•ASOA Annual Meeting A new and lively program joined the Sunday Summit General Session this year. Modeled after the popular NBC show "The Voice," a team of judges—complete with the iconic chairs—contestants, and a panel participated in "The Voice of Oph- thalmology." In the session, contestants pre- sented on the "most controversial topics in anterior segment surgery," said the competition's host Edward Holland, MD, Cincinnati. Judg- es—Eric Donnenfeld, MD, Rock- ville Centre, New York, Elizabeth Yeu, MD, Norfolk, Virginia, John Berdahl, MD, Sioux Falls, South continued on page 72

• Blank Page
• Blank Page (1)